A Study to Investigate the Effect of ASP1517 After Intermittent Oral Dosing in Dialysis Chronic Kidney Disease Patients With Anemia Compared With Darbepoetin as a Reference Drug
Clinical trial NCT01888445 · COMPLETED
Trial details
- NCT number
- NCT01888445
- Sponsor
- Astellas Pharma Inc
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-03-28
- Primary completion
- 2014-09-15
- Enrollment
- 130
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.